Concepedia

Laura Rodón

LR

6

Publications

1.2K

Citations

6

H-Index

2010

Active since

Affiliations

Institució Catalana de Recerca i Estudis Avançats(Current)

Vall d'Hebron Institute of Oncology

Vall d'Hebron Hospital Universitari

Universitat Autònoma de Barcelona

Laura Rodón is an author at Institució Catalana de Recerca i Estudis Avançats specializing in tumor biology, radiation oncology, and cell biology.

ORCID

Top concepts

Publications per year

2010–2020

6

Publications

6

TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma

Judit Anido, Andrea Sáez‐Borderías, Alba Gonzàlez-Juncà et al. · Cancer Cell · 2010 · 569 citations · Full text

, , +10

USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

Pieter J.A. Eichhorn, Laura Rodón, Alba Gonzàlez-Juncà et al. · Nature Medicine · 2012 · 396 citations

, , +6

Active CREB1 Promotes a Malignant TGFβ2 Autocrine Loop in Glioblastoma

Laura Rodón, Alba Gonzàlez-Juncà, María del Mar Inda et al. · Cancer Discovery · 2014 · 76 citations · Full text

USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination

Prasanna Vasudevan Iyengar, Patrick Jaynes, Laura Rodón et al. · Scientific Reports · 2015 · 56 citations · Full text

The next-generation RET inhibitor TPX-0046 is active in drug-resistant and naïve RET-driven cancer models.

Alexander Drilon, Dayong Zhai, Evan Rogers et al. · Journal of Clinical Oncology · 2020 · 50 citations

, , +17

Rows per page

1–5 of 6